vs
Side-by-side financial comparison of Great Lakes Dredge & Dock CORP (GLDD) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $256.5M, roughly 1.9× Great Lakes Dredge & Dock CORP). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 4.9%, a 1.9% gap on every dollar of revenue. On growth, Great Lakes Dredge & Dock CORP posted the faster year-over-year revenue change (26.5% vs -1.7%). Over the past eight quarters, Great Lakes Dredge & Dock CORP's revenue compounded faster (13.6% CAGR vs -0.1%).
Great Lakes Dredge and Dock Company is an American company providing construction services in dredging and land reclamation, currently the largest such provider in the United States. GLD&D operates primarily in the United States but conducts one-quarter of its business overseas. The company was based in Oak Brook, Illinois, but in October 2020 relocated its corporate headquarters to Houston, Texas.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
GLDD vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $256.5M | $493.8M |
| Net Profit | $12.6M | $33.7M |
| Gross Margin | 20.9% | — |
| Operating Margin | 12.7% | 9.9% |
| Net Margin | 4.9% | 6.8% |
| Revenue YoY | 26.5% | -1.7% |
| Net Profit YoY | -35.9% | 10.5% |
| EPS (diluted) | $0.19 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $256.5M | $493.8M | ||
| Q3 25 | $195.2M | $492.9M | ||
| Q2 25 | $193.8M | $468.8M | ||
| Q1 25 | $242.9M | $458.4M | ||
| Q4 24 | $202.8M | $502.4M | ||
| Q3 24 | $191.2M | $511.2M | ||
| Q2 24 | $170.1M | $504.3M | ||
| Q1 24 | $198.7M | $495.1M |
| Q4 25 | $12.6M | $33.7M | ||
| Q3 25 | $17.7M | $71.7M | ||
| Q2 25 | $9.7M | $39.3M | ||
| Q1 25 | $33.4M | $20.7M | ||
| Q4 24 | $19.7M | $30.5M | ||
| Q3 24 | $8.9M | $19.4M | ||
| Q2 24 | $7.7M | $-153.0M | ||
| Q1 24 | $21.0M | $4.0M |
| Q4 25 | 20.9% | — | ||
| Q3 25 | 22.4% | — | ||
| Q2 25 | 18.9% | — | ||
| Q1 25 | 28.6% | — | ||
| Q4 24 | 24.1% | — | ||
| Q3 24 | 19.0% | — | ||
| Q2 24 | 17.5% | — | ||
| Q1 24 | 22.9% | — |
| Q4 25 | 12.7% | 9.9% | ||
| Q3 25 | 14.4% | 13.8% | ||
| Q2 25 | 8.8% | 12.8% | ||
| Q1 25 | 20.6% | 7.0% | ||
| Q4 24 | 14.8% | 7.8% | ||
| Q3 24 | 8.7% | 6.6% | ||
| Q2 24 | 8.6% | -31.3% | ||
| Q1 24 | 15.8% | 3.2% |
| Q4 25 | 4.9% | 6.8% | ||
| Q3 25 | 9.1% | 14.5% | ||
| Q2 25 | 5.0% | 8.4% | ||
| Q1 25 | 13.8% | 4.5% | ||
| Q4 24 | 9.7% | 6.1% | ||
| Q3 24 | 4.6% | 3.8% | ||
| Q2 24 | 4.5% | -30.3% | ||
| Q1 24 | 10.6% | 0.8% |
| Q4 25 | $0.19 | $0.40 | ||
| Q3 25 | $0.26 | $0.84 | ||
| Q2 25 | $0.14 | $0.46 | ||
| Q1 25 | $0.49 | $0.24 | ||
| Q4 24 | $0.29 | $0.37 | ||
| Q3 24 | $0.13 | $0.23 | ||
| Q2 24 | $0.11 | $-1.84 | ||
| Q1 24 | $0.31 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.4M | $375.2M |
| Total DebtLower is stronger | $378.2M | $570.5M |
| Stockholders' EquityBook value | $517.1M | $865.9M |
| Total Assets | $1.3B | $2.2B |
| Debt / EquityLower = less leverage | 0.73× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.4M | $375.2M | ||
| Q3 25 | $12.7M | $340.1M | ||
| Q2 25 | $2.9M | $224.7M | ||
| Q1 25 | $11.3M | $99.0M | ||
| Q4 24 | $10.2M | $229.9M | ||
| Q3 24 | $12.0M | $103.8M | ||
| Q2 24 | $23.1M | $19.4M | ||
| Q1 24 | $22.8M | $8.0M |
| Q4 25 | $378.2M | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | $448.2M | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $517.1M | $865.9M | ||
| Q3 25 | $502.1M | $890.7M | ||
| Q2 25 | $481.9M | $833.8M | ||
| Q1 25 | $479.9M | $789.2M | ||
| Q4 24 | $448.9M | $764.9M | ||
| Q3 24 | $425.4M | $732.5M | ||
| Q2 24 | $418.0M | $706.5M | ||
| Q1 24 | $409.0M | $856.2M |
| Q4 25 | $1.3B | $2.2B | ||
| Q3 25 | $1.3B | $2.2B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $1.3B | $2.2B | ||
| Q3 24 | $1.1B | $2.1B | ||
| Q2 24 | $1.1B | $2.0B | ||
| Q1 24 | $1.1B | $2.2B |
| Q4 25 | 0.73× | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | 1.00× | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $79.7M | $114.1M |
| Free Cash FlowOCF − Capex | $50.3M | — |
| FCF MarginFCF / Revenue | 19.6% | — |
| Capex IntensityCapex / Revenue | 11.5% | — |
| Cash ConversionOCF / Net Profit | 6.31× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $99.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $79.7M | $114.1M | ||
| Q3 25 | $49.2M | $137.3M | ||
| Q2 25 | $56.9M | $137.2M | ||
| Q1 25 | $60.9M | $-117.5M | ||
| Q4 24 | $-13.5M | $133.0M | ||
| Q3 24 | $26.8M | $91.8M | ||
| Q2 24 | $18.4M | $107.0M | ||
| Q1 24 | $38.4M | $-125.2M |
| Q4 25 | $50.3M | — | ||
| Q3 25 | $13.2M | — | ||
| Q2 25 | $-3.7M | — | ||
| Q1 25 | $39.6M | — | ||
| Q4 24 | $-36.1M | — | ||
| Q3 24 | $-11.5M | — | ||
| Q2 24 | $-34.0M | — | ||
| Q1 24 | $26.5M | — |
| Q4 25 | 19.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | -1.9% | — | ||
| Q1 25 | 16.3% | — | ||
| Q4 24 | -17.8% | — | ||
| Q3 24 | -6.0% | — | ||
| Q2 24 | -20.0% | — | ||
| Q1 24 | 13.4% | — |
| Q4 25 | 11.5% | — | ||
| Q3 25 | 18.4% | — | ||
| Q2 25 | 31.3% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 20.0% | — | ||
| Q2 24 | 30.8% | — | ||
| Q1 24 | 6.0% | — |
| Q4 25 | 6.31× | 3.39× | ||
| Q3 25 | 2.77× | 1.91× | ||
| Q2 25 | 5.87× | 3.49× | ||
| Q1 25 | 1.82× | -5.66× | ||
| Q4 24 | -0.69× | 4.36× | ||
| Q3 24 | 3.02× | 4.72× | ||
| Q2 24 | 2.39× | — | ||
| Q1 24 | 1.83× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GLDD
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
